Tapewire

Nasdaq · USD

MDGL

MADRIGAL PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
3441
SEC CIK
0001157601
Parsed reports
271

Last 12 months

Inside the activity.

0 purchase rows · 202 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025036
Dec 2025034
Jan 2026066
Feb 202600
Mar 2026017
Apr 202600
May 2026013
Jun 202601
Jul 2026010
Aug 202601
Sep 2026024
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 13, 2025 Filed Aug 13, 2025 22:18 UTC SaleCommon Stock 1,754 $361.13 $633,423.77
Disclosure

SEC source: 0001236927-25-000007 · wk-form4_1755123534.xml · nonDerivative · entry 5

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 309,374

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $360.72 to $361.62, inclusive.

Read SEC document
August 13, 2025 Filed Aug 13, 2025 22:18 UTC SaleCommon Stock 3,153 $360.27 $1,135,937.62
Disclosure

SEC source: 0001236927-25-000007 · wk-form4_1755123534.xml · nonDerivative · entry 4

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 311,128

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $359.71 to $360.67, inclusive.

Read SEC document
August 13, 2025 Filed Aug 13, 2025 22:18 UTC SaleCommon Stock 455 $359.31 $163,484.96
Disclosure

SEC source: 0001236927-25-000007 · wk-form4_1755123534.xml · nonDerivative · entry 3

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 314,281

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $358.71 to $359.68, inclusive.

Read SEC document
August 13, 2025 Filed Aug 13, 2025 22:18 UTC SaleCommon Stock 1,600 $358.23 $573,171.04
Disclosure

SEC source: 0001236927-25-000007 · wk-form4_1755123534.xml · nonDerivative · entry 2

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 314,736

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.70 to $358.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 13, 2025 Filed Aug 13, 2025 22:18 UTC Exercise / conversionCommon Stock 129,172 $9.45 $1,220,675.40
Disclosure

SEC source: 0001236927-25-000007 · wk-form4_1755123534.xml · nonDerivative · entry 1

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 316,336

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:45 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 43,605 $0.00 Strike: $9.45 $0.00
Disclosure

SEC source: 0001236927-25-000005 · wk-form4_1755121546.xml · derivative · entry 17

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 129,172

Underlying: Common Stock · 43,605 shares

Expires 2026-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F15 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:45 UTC SaleCommon Stock 600 $359.81 $215,886.00
Disclosure

SEC source: 0001236927-25-000005 · wk-form4_1755121546.xml · nonDerivative · entry 14

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,164

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $359.78 to $359.87, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:45 UTC SaleCommon Stock 5,032 $358.83 $1,805,614.95
Disclosure

SEC source: 0001236927-25-000005 · wk-form4_1755121546.xml · nonDerivative · entry 13

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,764

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $358.48 to $359.41, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:45 UTC SaleCommon Stock 8,434 $357.93 $3,018,785.84
Disclosure

SEC source: 0001236927-25-000005 · wk-form4_1755121546.xml · nonDerivative · entry 12

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 192,796

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.48 to $358.47, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:45 UTC SaleCommon Stock 5,094 $356.94 $1,818,251.34
Disclosure

SEC source: 0001236927-25-000005 · wk-form4_1755121546.xml · nonDerivative · entry 11

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 201,230

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $356.48 to $357.46, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:45 UTC SaleCommon Stock 5,244 $355.97 $1,866,710.35
Disclosure

SEC source: 0001236927-25-000005 · wk-form4_1755121546.xml · nonDerivative · entry 10

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 206,324

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $355.48 to $356.46, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:45 UTC SaleCommon Stock 6,546 $355.00 $2,323,856.18
Disclosure

SEC source: 0001236927-25-000005 · wk-form4_1755121546.xml · nonDerivative · entry 9

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 211,568

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.48 to $355.47, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:45 UTC SaleCommon Stock 4,768 $354.06 $1,688,137.10
Disclosure

SEC source: 0001236927-25-000005 · wk-form4_1755121546.xml · nonDerivative · entry 8

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 218,114

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.48 to $354.47, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:45 UTC SaleCommon Stock 1,382 $352.61 $487,308.82
Disclosure

SEC source: 0001236927-25-000005 · wk-form4_1755121546.xml · nonDerivative · entry 7

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 222,882

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $352.48 to $353.47, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:45 UTC SaleCommon Stock 3,202 $351.59 $1,125,805.91
Disclosure

SEC source: 0001236927-25-000005 · wk-form4_1755121546.xml · nonDerivative · entry 6

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 224,264

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.16 to $352.12, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:45 UTC SaleCommon Stock 3,303 $350.93 $1,159,112.54
Disclosure

SEC source: 0001236927-25-000005 · wk-form4_1755121546.xml · nonDerivative · entry 5

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 227,466

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.16 to $351.14, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:45 UTC Exercise / conversionCommon Stock 43,605 $9.45 $412,067.25
Disclosure

SEC source: 0001236927-25-000005 · wk-form4_1755121546.xml · nonDerivative · entry 4

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 230,769

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:33 UTC
Taub RebeccaDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 43,263 $0.00 Strike: $9.45 $0.00
Disclosure

SEC source: 0001423898-25-000005 · wk-form4_1755120803.xml · derivative · entry 17

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 43,263 shares

Expires 2026-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F15 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:33 UTC
Taub RebeccaDirector
SaleCommon Stock 700 $359.71 $251,797.56
Disclosure

SEC source: 0001423898-25-000005 · wk-form4_1755120803.xml · nonDerivative · entry 14

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 461,044

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $359.51 to $359.78, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:33 UTC
Taub RebeccaDirector
SaleCommon Stock 6,541 $358.81 $2,346,982.75
Disclosure

SEC source: 0001423898-25-000005 · wk-form4_1755120803.xml · nonDerivative · entry 13

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 461,744

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $358.44 to $359.43, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:33 UTC
Taub RebeccaDirector
SaleCommon Stock 6,715 $357.85 $2,402,981.55
Disclosure

SEC source: 0001423898-25-000005 · wk-form4_1755120803.xml · nonDerivative · entry 12

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 468,285

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.44 to $358.43, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:33 UTC
Taub RebeccaDirector
SaleCommon Stock 4,864 $356.88 $1,735,861.40
Disclosure

SEC source: 0001423898-25-000005 · wk-form4_1755120803.xml · nonDerivative · entry 11

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 475,000

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $356.44 to $357.41, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:33 UTC
Taub RebeccaDirector
SaleCommon Stock 5,752 $355.95 $2,047,436.48
Disclosure

SEC source: 0001423898-25-000005 · wk-form4_1755120803.xml · nonDerivative · entry 10

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 479,864

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $355.44 to $356.43, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:33 UTC
Taub RebeccaDirector
SaleCommon Stock 6,479 $354.97 $2,299,873.31
Disclosure

SEC source: 0001423898-25-000005 · wk-form4_1755120803.xml · nonDerivative · entry 9

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 485,616

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.44 to $355.43, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:33 UTC
Taub RebeccaDirector
SaleCommon Stock 4,587 $354.04 $1,623,997.08
Disclosure

SEC source: 0001423898-25-000005 · wk-form4_1755120803.xml · nonDerivative · entry 8

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 492,095

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.43 to $354.42, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:33 UTC
Taub RebeccaDirector
SaleCommon Stock 1,175 $352.45 $414,130.40
Disclosure

SEC source: 0001423898-25-000005 · wk-form4_1755120803.xml · nonDerivative · entry 7

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 496,682

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $352.17 to $353.01, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:33 UTC
Taub RebeccaDirector
SaleCommon Stock 2,870 $351.60 $1,009,090.85
Disclosure

SEC source: 0001423898-25-000005 · wk-form4_1755120803.xml · nonDerivative · entry 6

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 497,857

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.16 to $352.12, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:33 UTC
Taub RebeccaDirector
SaleCommon Stock 3,580 $350.87 $1,256,127.13
Disclosure

SEC source: 0001423898-25-000005 · wk-form4_1755120803.xml · nonDerivative · entry 5

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 500,727

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.10 to $351.08, inclusive.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 21:33 UTC
Taub RebeccaDirector
Exercise / conversionCommon Stock 43,263 $9.45 $408,835.35
Disclosure

SEC source: 0001423898-25-000005 · wk-form4_1755120803.xml · nonDerivative · entry 4

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 504,307

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 21:45 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 3,203 $0.00 Strike: $9.45 $0.00
Disclosure

SEC source: 0001236927-25-000005 · wk-form4_1755121546.xml · derivative · entry 16

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 172,777

Underlying: Common Stock · 3,203 shares

Expires 2026-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F15 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 21:45 UTC SaleCommon Stock 300 $351.04 $105,312.33
Disclosure

SEC source: 0001236927-25-000005 · wk-form4_1755121546.xml · nonDerivative · entry 3

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,164

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.00 to $351.24, inclusive.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 21:45 UTC SaleCommon Stock 2,903 $350.19 $1,016,604.76
Disclosure

SEC source: 0001236927-25-000005 · wk-form4_1755121546.xml · nonDerivative · entry 2

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,464

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 21:45 UTC Exercise / conversionCommon Stock 3,203 $9.45 $30,268.35
Disclosure

SEC source: 0001236927-25-000005 · wk-form4_1755121546.xml · nonDerivative · entry 1

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 190,367

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 21:33 UTC
Taub RebeccaDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 3,200 $0.00 Strike: $9.45 $0.00
Disclosure

SEC source: 0001423898-25-000005 · wk-form4_1755120803.xml · derivative · entry 16

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,263

Underlying: Common Stock · 3,200 shares

Expires 2026-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F15 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 21:33 UTC
Taub RebeccaDirector
SaleCommon Stock 220 $351.02 $77,224.80
Disclosure

SEC source: 0001423898-25-000005 · wk-form4_1755120803.xml · nonDerivative · entry 3

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 461,044

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.00 to $351.24, inclusive.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 21:33 UTC
Taub RebeccaDirector
SaleCommon Stock 2,980 $350.18 $1,043,528.35
Disclosure

SEC source: 0001423898-25-000005 · wk-form4_1755120803.xml · nonDerivative · entry 2

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 461,264

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 21:33 UTC
Taub RebeccaDirector
Exercise / conversionCommon Stock 3,200 $9.45 $30,240.00
Disclosure

SEC source: 0001423898-25-000005 · wk-form4_1755120803.xml · nonDerivative · entry 1

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 464,244

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 01, 2025 Filed Aug 5, 2025 23:23 UTC GrantStock Option (Right to Buy) · Derivative 1,705 $0.00 Strike: $302.17 $0.00
Disclosure

SEC source: 0001628280-25-038008 · wk-form4_1754436199.xml · derivative · entry 2

Brennan Daniel J. · CIK 0001595612 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,705

Underlying: Common Stock · 1,705 shares

Expires 2035-08-01

F2 · derivative.exercise_date: The option vests as to 50% of the shares on the first anniversary of the date of grant (August 1, 2026) and, thereafter, 12.5% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.

Read SEC document
August 01, 2025 Filed Aug 5, 2025 23:23 UTC GrantCommon Stock 967 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-038008 · wk-form4_1754436199.xml · nonDerivative · entry 1

Brennan Daniel J. · CIK 0001595612 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 967

F1 · kind: Represents a grant of restricted stock units which vest as to 50% of the shares on each of August 1, 2026 and August 1, 2027, provided the Reporting Person continues in service with the Issuer on each such date.

Read SEC document
July 18, 2025 Filed Jul 22, 2025 21:06 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,400 $0.00 Strike: $9.45 $0.00
Disclosure

SEC source: 0001628280-25-035580 · wk-form4_1753218411.xml · derivative · entry 4

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 175,980

Underlying: Common Stock · 1,400 shares

Expires 2026-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable.

Read SEC document
July 18, 2025 Filed Jul 22, 2025 21:06 UTC SaleCommon Stock 1,400 $350.03 $490,043.96
Disclosure

SEC source: 0001628280-25-035580 · wk-form4_1753218411.xml · nonDerivative · entry 2

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,164

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
July 18, 2025 Filed Jul 22, 2025 21:06 UTC Exercise / conversionCommon Stock 1,400 $9.45 $13,230.00
Disclosure

SEC source: 0001628280-25-035580 · wk-form4_1753218411.xml · nonDerivative · entry 1

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 188,564

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 18, 2025 Filed Jul 22, 2025 21:08 UTC
Taub RebeccaDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 1,000 $0.00 Strike: $9.45 $0.00
Disclosure

SEC source: 0001628280-25-035583 · wk-form4_1753218526.xml · derivative · entry 4

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,463

Underlying: Common Stock · 1,000 shares

Expires 2026-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable.

Read SEC document
July 18, 2025 Filed Jul 22, 2025 21:08 UTC
Taub RebeccaDirector
SaleCommon Stock 1,000 $350.01 $350,005.00
Disclosure

SEC source: 0001628280-25-035583 · wk-form4_1753218526.xml · nonDerivative · entry 2

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 461,044

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
July 18, 2025 Filed Jul 22, 2025 21:08 UTC
Taub RebeccaDirector
Exercise / conversionCommon Stock 1,000 $9.45 $9,450.00
Disclosure

SEC source: 0001628280-25-035583 · wk-form4_1753218526.xml · nonDerivative · entry 1

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 462,044

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 17, 2025 Filed Jul 18, 2025 20:13 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 2,700 $0.00 Strike: $9.45 $0.00
Disclosure

SEC source: 0001628280-25-035342 · wk-form4_1752869569.xml · derivative · entry 14

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 177,380

Underlying: Common Stock · 2,700 shares

Expires 2026-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable.

Read SEC document
July 17, 2025 Filed Jul 18, 2025 20:13 UTC SaleCommon Stock 700 $351.57 $246,098.02
Disclosure

SEC source: 0001628280-25-035342 · wk-form4_1752869569.xml · nonDerivative · entry 11

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,164

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.17 to $352.00, inclusive.

Read SEC document
July 17, 2025 Filed Jul 18, 2025 20:13 UTC SaleCommon Stock 2,000 $350.10 $700,203.00
Disclosure

SEC source: 0001628280-25-035342 · wk-form4_1752869569.xml · nonDerivative · entry 10

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,864

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.61, inclusive.

Read SEC document
July 17, 2025 Filed Jul 18, 2025 20:13 UTC Exercise / conversionCommon Stock 2,700 $9.45 $25,515.00
Disclosure

SEC source: 0001628280-25-035342 · wk-form4_1752869569.xml · nonDerivative · entry 9

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 189,864

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 17, 2025 Filed Jul 18, 2025 20:11 UTC
Taub RebeccaDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 2,657 $0.00 Strike: $9.45 $0.00
Disclosure

SEC source: 0001628280-25-035340 · wk-form4_1752869497.xml · derivative · entry 14

Taub Rebecca · CIK 0001423898 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,463

Underlying: Common Stock · 2,657 shares

Expires 2026-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.